뉴스벤징가
Syndax Pharmaceuticals Suffers Pipeline Blow
· 발표
기사 요약
Syndax Pharmaceuticals halts axatilimab in idiopathic pulmonary fibrosis after the candidate misses the primary endpoint in a Phase 2 trial.
기사 원문에서 발췌했어요.뉴스 본문을 불러오고 있어요.
Syndax Pharmaceuticals halts axatilimab in idiopathic pulmonary fibrosis after the candidate misses the primary endpoint in a Phase 2 trial.
기사 원문에서 발췌했어요.
댓글 —
댓글을 불러오고 있어요…